uridine triphosphate has been researched along with losartan in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brailoiu, E; de Zeeuw, D; Deelman, LE; Filipeanu, CM; Henning, RH; Nelemans, SA | 1 |
Ishida, K; Kamata, K; Kobayashi, T; Matsumoto, T; Taguchi, K | 1 |
2 other study(ies) available for uridine triphosphate and losartan
Article | Year |
---|---|
Intracellular angiotensin II inhibits heterologous receptor stimulated Ca2+ entry.
Topics: Angiotensin II; Animals; Calcium; Cell Line; Imidazoles; Liposomes; Losartan; Muscle, Smooth; Pyridines; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Serotonin; Uridine Triphosphate | 2001 |
Mechanisms underlying altered extracellular nucleotide-induced contractions in mesenteric arteries from rats in later-stage type 2 diabetes: effect of ANG II type 1 receptor antagonism.
Topics: Adenosine Triphosphate; Angiotensin II Type 1 Receptor Blockers; Animals; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dinoprost; Dinoprostone; Disease Models, Animal; Group IV Phospholipases A2; Losartan; Male; Membrane Proteins; Mesenteric Artery, Superior; Phosphorylation; Purinergic P2 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P2; Receptors, Purinergic P2Y2; Signal Transduction; Superoxides; Uridine Triphosphate; Vasoconstriction | 2011 |